|
Originally published In Press as doi:10.1074/jbc.M108476200 on October 26, 2001
J. Biol. Chem., Vol. 277, Issue 1, 218-224, January 4, 2002
ASB-2 Inhibits Growth and Promotes Commitment in Myeloid Leukemia
Cells*
Florence C.
Guibal ,
Christel
Moog-Lutz ,
Piotr
Smolewski§,
Yolande
Di Gioia ,
Zbigniew
Darzynkiewicz§,
Pierre G.
Lutz ¶, and
Yvon E.
Cayre ¶ **
From the Unité INSERM U417, Hôpital Saint
Antoine, 184 Rue du Faubourg Saint Antoine, 75012 Paris, France,
the § Brander Cancer Research Institute, New York Medical
College, Hawthorne, New York 10532, and the Department of
Microbiology/Immunology, Kimmel Cancer Institute, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107-5541
In acute promyelocytic leukemia (APL) cells
harboring the promyelocytic leukemia retinoic acid receptor (PML-RAR ) chimeric protein, retinoic acid (RA)-induced
differentiation is triggered through a PML-RAR signaling resulting
in activation of critical target genes. Induced differentiation of APL
cells is always preceded by withdrawal from the cell cycle and
commitment events leading to terminal differentiation. Here we have
identified the human ankyrin repeat-containing protein with a
suppressor of cytokine signaling box-2 (ASB-2) cDNA, as a novel
RA-induced gene in APL cells. PML-RAR strongly enhanced RA-induced
ASB-2 mRNA expression. In myeloid leukemia cells, ASB-2 expression
induced growth inhibition and chromatin condensation recapitulating
early events critical to RA-induced differentiation of APL cells.
*
This work was supported by INSERM; by CNRS; by grants from
the Fondation de France, the Comité de Paris de La Ligue Contre le Cancer, the Association Pour la Recherche sur le Cancer, the Association Combattre la Leucémie, the Lady Tata Memorial Trust, the Leukemia Research Foundation; and by National Institutes of Health
Grant RO-1 28704 (to Z. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ251238.
¶
These authors should be considered as equal last authors.
**
To whom correspondence should be addressed: Unité INSERM
U417, Hôpital Saint Antoine, 184 Rue du Faubourg Saint Antoine, 75012 Paris, France. Tel.: 33-1-49284613; Fax: 33-1-43406837; E-mail: cayre@st-antoine.inserm.fr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. F. Burande, M. L. Heuze, I. Lamsoul, B. Monsarrat, S. Uttenweiler-Joseph, and P. G. Lutz
A Label-free Quantitative Proteomics Strategy to Identify E3 Ubiquitin Ligase Substrates Targeted to Proteasome Degradation
Mol. Cell. Proteomics,
July 1, 2009;
8(7):
1719 - 1727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Heuze, I. Lamsoul, M. Baldassarre, Y. Lad, S. Leveque, Z. Razinia, C. Moog-Lutz, D. A. Calderwood, and P. G. Lutz
ASB2 targets filamins A and B to proteasomal degradation
Blood,
December 15, 2008;
112(13):
5130 - 5140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. McDaneld and D. M. Spurlock
Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt
J Anim Sci,
November 1, 2008;
86(11):
2897 - 2902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-L. Liu, J.-Y. Yuan, J.-W. Zhang, X.-H. Zhang, and R.-X. Wang
Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage
J. Leukoc. Biol.,
October 1, 2007;
82(4):
986 - 1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Debrincat, J.-G. Zhang, T. A. Willson, J. Silke, L. M. Connolly, R. J. Simpson, W. S. Alexander, N. A. Nicola, B. T. Kile, and D. J. Hilton
Ankyrin Repeat and Suppressors of Cytokine Signaling Box Protein Asb-9 Targets Creatine Kinase B for Degradation
J. Biol. Chem.,
February 16, 2007;
282(7):
4728 - 4737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. McDaneld, K. Hannon, and D. E. Moody
Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2006;
290(6):
R1672 - R1682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Heuze, F. C. Guibal, C. A. Banks, J. W. Conaway, R. C. Conaway, Y. E. Cayre, A. Benecke, and P. G. Lutz
ASB2 Is an Elongin BC-interacting Protein That Can Assemble with Cullin 5 and Rbx1 to Reconstitute an E3 Ubiquitin Ligase Complex
J. Biol. Chem.,
February 18, 2005;
280(7):
5468 - 5474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. McDaneld, D. L. Hancock, and D. E. Moody
Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of {beta}-adrenergic receptor agonists
Physiol Genomics,
January 15, 2004;
16(2):
275 - 283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Moog-Lutz, F. Cave-Riant, F. C. Guibal, M. A. Breau, Y. Di Gioia, P. O. Couraud, Y. E. Cayre, S. Bourdoulous, and P. G. Lutz
JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells
Blood,
November 1, 2003;
102(9):
3371 - 3378.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|